These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 17437402)

  • 1. Potential impact of AUSFTA on Australia's blood supply.
    Kennedy GA; Cummings J; Durrant ST
    Med J Aust; 2007 Apr; 186(8):427; author reply 430. PubMed ID: 17437402
    [No Abstract]   [Full Text] [Related]  

  • 2. Human T-lymphotropic virus seroconversion associated with pooled human intravenous immunoglobulin therapy.
    Hunter M; Kiernan MC; Post J
    Intern Med J; 2012 Jun; 42(6):729-30. PubMed ID: 22697159
    [No Abstract]   [Full Text] [Related]  

  • 3. Potential impact of AUSFTA on Australia's blood supply.
    Farrugia A
    Med J Aust; 2007 Jun; 186(12):660. PubMed ID: 17576189
    [No Abstract]   [Full Text] [Related]  

  • 4. Potential impact of AUSFTA on Australia's blood supply. Comment.
    Frenzel W
    Med J Aust; 2007 Apr; 186(8):427-8; author reply 430. PubMed ID: 17511050
    [No Abstract]   [Full Text] [Related]  

  • 5. Lessons from human T-lymphotropic virus testing.
    Leparc GF
    Transfusion; 2011 Apr; 51(4):668-9. PubMed ID: 21496036
    [No Abstract]   [Full Text] [Related]  

  • 6. Serologic and molecular typing of human T-lymphotropic virus among blood donors in Maputo City, Mozambique.
    Gudo ES; Abreu CM; Mussá T; Augusto Ado R; Otsuki K; Chambo E; Amade N; Tanuri A; Ferreira OC; Jani IV;
    Transfusion; 2009 Jun; 49(6):1146-50. PubMed ID: 19222818
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Potential impact of AUSFTA on Australia's blood supply.
    Turner A; Farrugia A
    Med J Aust; 2007 Apr; 186(8):428-30; author reply 430. PubMed ID: 17508452
    [No Abstract]   [Full Text] [Related]  

  • 8. Potential impact of AUSFTA on Australia's blood supply.
    Bambrick HJ; Faunce TA; Johnston K
    Med J Aust; 2006 Sep; 185(6):320-3. PubMed ID: 16999673
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum interferon concentrations and retroviral serology in Kawasaki syndrome.
    Rowley AH; Shulman ST; Preble OT; Poiesz BJ; Ehrlich GD; Sullivan JR
    Pediatr Infect Dis J; 1988 Sep; 7(9):663-6. PubMed ID: 3140211
    [No Abstract]   [Full Text] [Related]  

  • 10. Seroprevalence of human T-lymphotropic virus type 1 and 2 in Korean blood donors.
    Kwon SY; Lim AH; Park JY; Han SH; Cho NS
    J Med Virol; 2008 Oct; 80(10):1864-7. PubMed ID: 18712809
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of human T-cell lymphotropic virus-I/II-indeterminate reactivities in a Greek blood bank population.
    Tseliou PM; Spiliotakara A; Politis C; Spanakis N; Legakis NJ; Tsakris A
    Transfus Med; 2004 Jun; 14(3):253-4. PubMed ID: 15180821
    [No Abstract]   [Full Text] [Related]  

  • 12. Seroprevalence of human T lymphtropic virus (HTLV) among tissue donors in Iranian tissue bank.
    Arjmand B; Aghayan SH; Goodarzi P; Farzanehkhah M; Mortazavi SM; Niknam MH; Jafarian A; Arjmand F; Jebelly far S
    Cell Tissue Bank; 2009 Aug; 10(3):247-52. PubMed ID: 19037751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Absence of antibody to HTLV-1 in sera of Asian Indian patients with systemic autoimmune rheumatic diseases.
    Danda D; Ramalingam S; Kannagai R; Jayaprakash K; Thomas K; Babu PG
    Trop Doct; 2004 Apr; 34(2):126. PubMed ID: 15117159
    [No Abstract]   [Full Text] [Related]  

  • 14. Long-term serologic follow-up of blood donors with biologic false reactivity on an anti-human T-cell lymphotropic virus Types I and II chemiluminescent immunoassay and implications for donor management.
    Kiely P; Thomas B; Kebede M
    Transfusion; 2008 Sep; 48(9):1833-41. PubMed ID: 18503614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular evidence of human T-cell lymphotropic virus types 1 and 2 (HTLV-1 and HTLV-2) infections in HTLV seroindeterminate individuals from São Paulo, Brazil.
    Costa JM; Segurado AC
    J Clin Virol; 2009 Mar; 44(3):185-9. PubMed ID: 19188090
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prenatal screening for Trypanosoma cruzi and human T lymphotropic virus types 1 and 2 in pregnant Latin American women].
    Ramos JM; Milla A; Sánchez V; Vergés M; Toro C; Gutiérrez F
    Enferm Infecc Microbiol Clin; 2009 Mar; 27(3):165-7. PubMed ID: 19306717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of signal-to-cutoff values in first, second, and third generation enzyme immunoassays for the diagnosis of HTLV-1/2 infection in "at-risk" individuals from São Paulo, Brazil.
    Jacob F; Magri MC; Costa EA; Santos-Fortuna E; Caterino-de-Araujo A
    J Virol Methods; 2009 Aug; 159(2):288-90. PubMed ID: 19490981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intravenous immunoglobulin in Australia. Supply and demand.
    Penny R
    Vox Sang; 2002 Aug; 83 Suppl 1():447-51. PubMed ID: 12617184
    [No Abstract]   [Full Text] [Related]  

  • 19. HIV/human T-cell lymphotropic virus coinfection revisited: impact on AIDS progression.
    Brites C; Sampalo J; Oliveira A
    AIDS Rev; 2009; 11(1):8-16. PubMed ID: 19290030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Absence of exogenous retroviruses in Felty's syndrome.
    Nelson PN; Bowman SJ; Hay FC; Lanchbury JS; Panayi GS; Lever AM
    Br J Rheumatol; 1995 Feb; 34(2):185-7. PubMed ID: 7704473
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.